Rosuvastatin Calcium IP 5mg/10mg + Fenofibrate BP 160mg/160mg tablet  now in new DCGI molecule approved by our honorable DCGI for its additional strength on 29-12-2010. 

The combination shows very good results in patients with hyperlipidaemia.

For details of the research of the combination, kindly mail to meditextchd@gmail.com.